PF-07321332/ritonavir

· Pfizer

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for PF-07321332/ritonavir, covering 2023-07-13 to 2024-03-29. Get the full timeline:

Most recent: Clinical Trial Update: PF-07321332/Ritonavir and Ritonavir on Dabigatran Study in Healthy Participants [Phase 1]